Trial intelligence / Profile preview

Dilapan vs Misoprostol for Midtrimester Abortion

NCT05147857Unknown

Sponsor
Ain Shams University Maternity Hospital
Start
Jan 2021
Primary completion
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of misoprostol (2 arms), sponsored by Ain Shams University Maternity Hospital. Primary endpoint: Abortion at 24 hours. Status: unknown.

02

Drugs

misoprostol

Beyond the preview

Go deeper on NCT05147857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05147857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call